expression includes the p21 gene, a target for viral regulation // Journal of Virology. — 2005. — Vol. 79, № 7. — P. 4479–4491.
Vernazza P. L., Gilliam B. L., Dyer J. et al. Quantification of HIV in semen: correlation with antiviral treatment and immune status // AIDS. — 1997. — Vol. 11, № 11. — P. 987–993.
Wahl S. M., Greenwell-Wild T., Peng G. et al . Co-infection with opportunistic pathogens promotes human immunodeficiency virus type 1 infection in macrophages // J. Infect. Dis. — 1999. — Vol. 179. — P. 457–460.
Wahl S. M., Greenwell-Wild T., Hale-Donze H. et al. Permissive factors for HIV-1 infection of macrophages //J. Leukoc. Biol. — 2000. — Vol. 68. — P. 303–310.
Wahl S., Greenwell-Wild T., Gang Peng et al . Viral and host cofactors facilitate HIV-1 replication in macrophages // J. Leukoc. Biol. — 2003. —Vol. 74. — P. 726–735.
Wahl S., Greenwell-Wild T., Vazquez N. HIV accomplices and adversaries in macrophage infection // J. Leukoc. Biol. — 2006. — Vol. 80. — P. 973–983.
van den Broek J., Chum H. J., Swai R. et al. Association between leprosy and HIV infection in Tanzania // Int. J. Lepr. Other Mycobact. Dis. — 1997. — Vol. 65, № 2. — P. 203–210.
Wang S. Z., Rushlow K. E., Issel C. J. et al. Enhancement of EIAV replication and disease by immunization with a baculovirus-expressed recombinant envelope surface glycoprotein // Virology — 1994. — Vol. 199. — P. 247–251.
Wang-Johanning F., Frost A. R., Jian B. et al. Quantitation of HERV-K env gene expression and splicing in human breast cancer // Oncogene. — 2003. — Vol. 22. — P. 1528–1535.
Weichenrieder O., Wild K., Strub K. et al. Structure and assembly of the Alu domain of the mammalian signal recognition particle // Nature. — 2000. — Vol. 408. — P. 167–173.
Weisburg W. G., Woese C. R., Dobson M. E. et al. A common origin of rickettsiae and certain plant pathogens // Science. — 1985. — Vol. 230. — P. 556–558.
Wei X., Decker J.M., Hui H. et al. Antibody neutralization and escape by HIV-1 // Nature. — 2003. — Vol. 422, № 6929. — P. 307–312.
Werner G.T., Jentzsch U., Metzger E. et al. // Arch. Virol. — 1968. — Vol. 64, № 3. — P. 247–256.
Westby M., Lewis M., Whitcomb J. et al . Emergence of CXCR4-using human immunodeficiency virus type 1 (HIV-1) variants in a minority of HIV-1-infected patients following treatment with the CCR5 antagonist maraviroc is from a pretreatment CXCR4-using virus reservoir // Journal of Virology. — 2006. — Vol. 80, № 10. — Р. 4909–4920.
Wilson A., Symons J., McDowell T. et. al . Effects of polymorphism in the tumor necrosis factor alpha promoter on transcriptional activation // Proc. Natl. Acad. Sci. USA. — 1997. — Vol. 94, № 10. — P. 3195–3199.
Winiecka-Krusnell J., Wreiber K., A. von Euler L. et al. Free-living amoebae promote growth and survival of Helicobacter pylori // Scand. J. Infect. Dis. — 2002. — Vol. 34. — P. 253–256.
Wood D., Richmond B. Human evolution: taxonomy and paleobiology // J. Anat. — 2000. — Vol. 196. — P. 19–60.
Wolfe N. D. et al . Wild primate populations in emerging infectious disease research: the missing link? // Emerg. Infect. Dis. — 1998. — Vol. 4? № 2. — P. 1 49 —1 58.
Wolf T. F., DeJong J., Van Den Berg H. et al . Evolution of sequences encoding the principal neutralization epitope of human immunodeficiency virus type 1 is host dependent, rapid and continuous // Proc. Natl. Acad. Sci. USA. — 1990. — Vol. 87. — P. 9938–9942.
Woude S.V., Apetrei C. Going Wild: Lessons from Naturally Occurring T-Lymphotropic Lentiviruses // Clinical Microbiology Revievs. — 2006. — Vol. 19, № 4. — P. 728–762.
Wu Lien-Ten U.A., Chun J.W., Pollitzen R. et al . Plague. A manual for medical and public health workers. — Shanghai, 1936.
Wu S., Spouge J., Conley S. et al . Human plasma enhances the infectivity of primary human immunodeficiency virus type 1 isolates in peripheral blood mononuclear cells and monocyte-derived macrophages // Journal of Virology. — 1995. — Vol. 69, № 10. — P. 6054–6062.
Wyatt R., Kwong P.D., Desjardins E. et al. Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody // Nature. — 1998. — Vol. 393. — P. 705–711.
Xin-He Lai, Golovliov I., Sjostedt A. Francisella tularensis induces cytopathogenicity and apoptosis in murine macrophages via a mechanism that requires intracellular bacterial multiplication // Infection and Immunity. — 2001. — Vol. 69, № 7. — P. 4691–4694.
Xu R., Johnson A., Liggitt D. et al. Cellular and humoral immunity against vaccinia virus infection of mice // The Journal of Immunology. — 2004. — Vol. 172. — P. 6265–6271.
Xuminer D., Rosenfeld G.B., Pitlik S.D. AIDS in pre-AIDS era // Rev. Infect. Dis. — 1987. — Vol.9. — P.1102–1109.
Yoneyama H., Harada A., Imai T. et al. Pivotal role of TARC, a CC chemokine, in bacteria-induced fulminant hepatic failure in mice // J. Clin. Investig. — 1998. — Vol. 102. — P. 1933–1941.
Zagury D. Anti-HIV cellular immunotherapy in AIDS // Lancet. — 1991. — Vol. 338, № 8768. — P. 694–695.
Zennou V., Perez-Caballero D., Gottlinger H. et al. APOBEC3G incorporation into human immunodeficiency virus type 1 particles // J. Virol. — 2004. — Vol. 78. — P. 12058 — 12061.
Zhang F., Hatziioannou T., Perez-Caballero D. et al. Antiretroviral potential of human tripartite motif-5 and related proteins // Virology. — 2006.
Zhang Kun-Lin, Mangeat B., Ortiz M. et al . Model structure of human APOBEC3G // PLoS ONE. — 2007. — Vol. 2, № 4. — Р. 1–6.
Zhang H., Hoffmann F., He J. et al . Evolution of subtype C HIV-1 Env in a slowly progressing Zambian infant // Retrovirology. — 2005 (http://www.retrovirology.com/content/2/1/6).
Zhantao Yang, Zhinyi Cao, Panjwani N. Pathogenesis of Acanthamoeba keratitis: carbohydrate mediated host-parasite interactions // Infection and Immunity. — 1997. — Vol. 65, №. 2. — P. 439–445.
Zhu Z. B, Hsieh S. L, Bentley D. R. et al. A variable number of tandem repeats locus within the human complement C2 gene is associated with a retroposon derived from a human endogenous retrovirus // J. Exp. Med. — 1992. — Vol. 175. — P. 1783–1787
Zwick M. B., Labrijn A.F., Wang M. et al. Broadly neutralizing antibodies targeted to the membrane-proximal external region of human immunodeficiency virus type 1 glycoprotein gp41 // J. Virol. — 2001. — Vol. 75. — P. 10892 — 10905.
Zwick M.B., Saphire E.O., Burton D.R. gp41: HIV's shy protein // Nat. Med. — 2004. — Vol. 10. — P. 133–134.